Array BioPharma Inc - Product Pipeline Review - 2016

Published: Dec, 2016 | Pages: 71 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Array BioPharma Inc - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Array BioPharma Inc - Product Pipeline Review - 2016', provides an overview of the Array BioPharma Inc's pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Array BioPharma Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Array BioPharma Inc
- The report provides overview of Array BioPharma Inc including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Array BioPharma Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Array BioPharma Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Array BioPharma Inc's strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Array BioPharma Inc
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Array BioPharma Inc's pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

 Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Array BioPharma Inc Snapshot 7
Array BioPharma Inc Overview 7
Key Facts 7
Array BioPharma Inc - Research and Development Overview 8
Key Therapeutic Areas 8
Array BioPharma Inc - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products - Combination Treatment Modalities 13
Pipeline Products - Partnered Products 14
Partnered Products/Combination Treatment Modalities 15
Pipeline Products - Out-Licensed Products 16
Out-Licensed Products/Combination Treatment Modalities 17
Array BioPharma Inc - Pipeline Products Glance 19
Array BioPharma Inc - Late Stage Pipeline Products 19
Pre-Registration Products/Combination Treatment Modalities 19
Phase III Products/Combination Treatment Modalities 20
Array BioPharma Inc - Clinical Stage Pipeline Products 21
Phase II Products/Combination Treatment Modalities 21
Phase I Products/Combination Treatment Modalities 22
Array BioPharma Inc - Early Stage Pipeline Products 23
Preclinical Products/Combination Treatment Modalities 23
Discovery Products/Combination Treatment Modalities 24
Array BioPharma Inc - Drug Profiles 25
AR-00457679 - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
AR-460770 - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
AR-523 - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
AR-786 - Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
ARRY-111 - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
ARRY-382 - Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
ARRY-797 - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
ARRY-954 - Drug Profile 35
Product Description 35
Mechanism Of Action 35
R&D Progress 35
binimetinib - Drug Profile 36
Product Description 36
Mechanism Of Action 36
R&D Progress 36
binimetinib + encorafenib - Drug Profile 45
Product Description 45
Mechanism Of Action 45
R&D Progress 45
encorafenib - Drug Profile 49
Product Description 49
Mechanism Of Action 49
R&D Progress 49
Small Molecules for Inflammation - Drug Profile 53
Product Description 53
Mechanism Of Action 53
R&D Progress 53
Array BioPharma Inc - Pipeline Analysis 54
Array BioPharma Inc - Pipeline Products by Target 54
Array BioPharma Inc - Pipeline Products by Route of Administration 56
Array BioPharma Inc - Pipeline Products by Molecule Type 57
Array BioPharma Inc - Pipeline Products by Mechanism of Action 58
Array BioPharma Inc - Dormant Projects 60
Array BioPharma Inc - Discontinued Pipeline Products 61
Discontinued Pipeline Product Profiles 61
ARRY-797 61
AZD-8330 61
binimetinib 61
GDC-0425 62
GDC-0994 62
Mutant cKIT Inhibitor for GIST 62
rabusertib 62
selumetinib sulfate 62
Array BioPharma Inc - Company Statement 63
Array BioPharma Inc - Locations And Subsidiaries 69
Head Office 69
Other Locations & Subsidiaries 69
Appendix 70
Methodology 70
Coverage 70
Secondary Research 70
Primary Research 70
Expert Panel Validation 70
Contact Us 70
Disclaimer 71

List of Tables

Array BioPharma Inc, Key Facts 7
Array BioPharma Inc - Pipeline by Indication, 2016 9
Array BioPharma Inc - Pipeline by Stage of Development, 2016 11
Array BioPharma Inc - Monotherapy Products in Pipeline, 2016 12
Array BioPharma Inc - Combination Treatment Modalities in Pipeline, 2016 13
Array BioPharma Inc - Partnered Products in Pipeline, 2016 14
Array BioPharma Inc - Partnered Products/ Combination Treatment Modalities, 2016 15
Array BioPharma Inc - Out-Licensed Products in Pipeline, 2016 16
Array BioPharma Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016 17
Array BioPharma Inc - Pre-Registration, 2016 19
Array BioPharma Inc - Phase III, 2016 20
Array BioPharma Inc - Phase II, 2016 21
Array BioPharma Inc - Phase I, 2016 22
Array BioPharma Inc - Preclinical, 2016 23
Array BioPharma Inc - Discovery, 2016 24
Array BioPharma Inc - Pipeline by Target, 2016 55
Array BioPharma Inc - Pipeline by Route of Administration, 2016 56
Array BioPharma Inc - Pipeline by Molecule Type, 2016 57
Array BioPharma Inc - Pipeline Products by Mechanism of Action, 2016 59
Array BioPharma Inc - Dormant Developmental Projects,2016 60
Array BioPharma Inc - Discontinued Pipeline Products, 2016 61
Array BioPharma Inc, Other Locations 69